(Q48622786)

English

Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments.

scientific article published in July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

author name string

Alon Kedem

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Ariel Hourvitz

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Yuval Yung

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Libby Shalev

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Gil M Yerushalmi

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Hannah Kanety

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Mirit Hanochi

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Ettie Maman

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

publication date

1 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

29

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

651-656

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone remains highly expressed in human cumulus cells during the final stages of folliculogenesis

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Viable embryos from injection of round spermatids into oocytes.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

High expression of luteinizing hormone receptors messenger RNA by human cumulus granulosa cells is in correlation with decreased fertilization.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Concentration of anti-Müllerian hormone and inhibin-B in relation to steroids and age in follicular fluid from small antral human follicles

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Polycystic ovary syndrome and its developmental origins.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Identifiers

10.3109/09513590.2013.798279

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48622786&oldid=946160155"